Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

New Drug Application (NDA): 050581
Company: MERCK
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
MEFOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER CEFOXITIN SODIUM EQ 20MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** INJECTABLE;INJECTION Discontinued None Yes No
MEFOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER CEFOXITIN SODIUM EQ 40MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** INJECTABLE;INJECTION Discontinued None Yes No
MEFOXIN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER CEFOXITIN SODIUM EQ 40MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** INJECTABLE;INJECTION Discontinued None Yes No
MEFOXIN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER CEFOXITIN SODIUM EQ 20MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** INJECTABLE;INJECTION Discontinued None Yes No
Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
02/27/1997 SUPPL-20 Review

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/nda/97/50-517s031_50-581s020_Mefoxin.cfm

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English